BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 35624717)

  • 1. Oxidative Stress in Cancer Immunotherapy: Molecular Mechanisms and Potential Applications.
    Liu R; Peng L; Zhou L; Huang Z; Zhou C; Huang C
    Antioxidants (Basel); 2022 Apr; 11(5):. PubMed ID: 35624717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms and applications of radiation-induced oxidative stress in regulating cancer immunotherapy.
    Zheng Z; Su J; Bao X; Wang H; Bian C; Zhao Q; Jiang X
    Front Immunol; 2023; 14():1247268. PubMed ID: 37600785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress in the tumor microenvironment in gastric cancer and its potential role in immunotherapy.
    Yu Y; Wu Y; Zhang Y; Lu M; Su X
    FEBS Open Bio; 2023 Jul; 13(7):1238-1252. PubMed ID: 37171226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A stressful microenvironment: opposing effects of the endoplasmic reticulum stress response in the suppression and enhancement of adaptive tumor immunity.
    Rausch MP; Sertil AR
    Int Rev Immunol; 2015 Mar; 34(2):104-22. PubMed ID: 25774773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer.
    Chouaib S; Noman MZ; Kosmatopoulos K; Curran MA
    Oncogene; 2017 Jan; 36(4):439-445. PubMed ID: 27345407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative Stress in the Tumor Microenvironment and Its Relevance to Cancer Immunotherapy.
    Aboelella NS; Brandle C; Kim T; Ding ZC; Zhou G
    Cancers (Basel); 2021 Feb; 13(5):. PubMed ID: 33673398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives.
    Thomas R; Al-Khadairi G; Roelands J; Hendrickx W; Dermime S; Bedognetti D; Decock J
    Front Immunol; 2018; 9():947. PubMed ID: 29770138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving cancer immunotherapy by targeting tumor-induced immune suppression.
    Stewart TJ; Smyth MJ
    Cancer Metastasis Rev; 2011 Mar; 30(1):125-40. PubMed ID: 21249424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbial hydrogen "manufactory" for enhanced gas therapy and self-activated immunotherapy via reduced immune escape.
    Yan H; Fan M; Liu H; Xiao T; Han D; Che R; Zhang W; Zhou X; Wang J; Zhang C; Yang X; Zhang J; Li Z
    J Nanobiotechnology; 2022 Jun; 20(1):280. PubMed ID: 35705974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress and lymphocyte persistence: implications in immunotherapy.
    Mehrotra S; Mougiakakos D; Johansson CC; Voelkel-Johnson C; Kiessling R
    Adv Cancer Res; 2009; 102():197-227. PubMed ID: 19595310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reverting Immune Suppression to Enhance Cancer Immunotherapy.
    Guerrouahen BS; Maccalli C; Cugno C; Rutella S; Akporiaye ET
    Front Oncol; 2019; 9():1554. PubMed ID: 32039024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanosonosensitizers With Ultrasound-Induced Reactive Oxygen Species Generation for Cancer Sonodynamic Immunotherapy.
    Cheng D; Wang X; Zhou X; Li J
    Front Bioeng Biotechnol; 2021; 9():761218. PubMed ID: 34660560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunity and immune suppression in human ovarian cancer.
    Preston CC; Goode EL; Hartmann LC; Kalli KR; Knutson KL
    Immunotherapy; 2011 Apr; 3(4):539-56. PubMed ID: 21463194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bladder cancer, a unique model to understand cancer immunity and develop immunotherapy approaches.
    Song D; Powles T; Shi L; Zhang L; Ingersoll MA; Lu YJ
    J Pathol; 2019 Oct; 249(2):151-165. PubMed ID: 31102277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactive Oxygen Species and Antitumor Immunity-From Surveillance to Evasion.
    Kotsafti A; Scarpa M; Castagliuolo I; Scarpa M
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32630174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging role of immunotherapy in urothelial carcinoma-Immunobiology/biomarkers.
    Sweis RF; Galsky MD
    Urol Oncol; 2016 Dec; 34(12):556-565. PubMed ID: 27836246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative Stress-Inducing Anticancer Therapies: Taking a Closer Look at Their Immunomodulating Effects.
    Van Loenhout J; Peeters M; Bogaerts A; Smits E; Deben C
    Antioxidants (Basel); 2020 Nov; 9(12):. PubMed ID: 33260826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor cell oxidative metabolism as a barrier to PD-1 blockade immunotherapy in melanoma.
    Najjar YG; Menk AV; Sander C; Rao U; Karunamurthy A; Bhatia R; Zhai S; Kirkwood JM; Delgoffe GM
    JCI Insight; 2019 Mar; 4(5):. PubMed ID: 30721155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of regulatory T cells in cancer immunity.
    Takeuchi Y; Nishikawa H
    Int Immunol; 2016 Aug; 28(8):401-9. PubMed ID: 27160722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual Inhibition of Endoplasmic Reticulum Stress and Oxidation Stress Manipulates the Polarization of Macrophages under Hypoxia to Sensitize Immunotherapy.
    Jiang M; Li X; Zhang J; Lu Y; Shi Y; Zhu C; Liu Y; Qin B; Luo Z; Du Y; Luo L; Peng L; You J
    ACS Nano; 2021 Sep; 15(9):14522-14534. PubMed ID: 34414762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.